Danaher Co. (NYSE:DHR) Position Reduced by Mckinley Capital Management LLC Delaware

Mckinley Capital Management LLC Delaware trimmed its stake in shares of Danaher Co. (NYSE:DHR) by 10.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 196,130 shares of the conglomerate’s stock after selling 23,116 shares during the quarter. Danaher makes up 1.8% of Mckinley Capital Management LLC Delaware’s portfolio, making the stock its 16th biggest position. Mckinley Capital Management LLC Delaware’s holdings in Danaher were worth $28,031,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. State of Wisconsin Investment Board boosted its stake in Danaher by 12.9% during the 1st quarter. State of Wisconsin Investment Board now owns 692,865 shares of the conglomerate’s stock valued at $91,472,000 after acquiring an additional 79,287 shares during the last quarter. Capital Advisors Ltd. LLC lifted its position in shares of Danaher by 527.5% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 320 shares of the conglomerate’s stock worth $46,000 after buying an additional 269 shares during the last quarter. Mitchell Capital Management Co. lifted its position in shares of Danaher by 20.7% in the 1st quarter. Mitchell Capital Management Co. now owns 12,174 shares of the conglomerate’s stock worth $1,607,000 after buying an additional 2,088 shares during the last quarter. Rehmann Capital Advisory Group lifted its position in shares of Danaher by 11.1% in the 1st quarter. Rehmann Capital Advisory Group now owns 2,014 shares of the conglomerate’s stock worth $266,000 after buying an additional 202 shares during the last quarter. Finally, Findlay Park Partners LLP lifted its position in shares of Danaher by 0.9% in the 1st quarter. Findlay Park Partners LLP now owns 4,635,000 shares of the conglomerate’s stock worth $611,913,000 after buying an additional 40,000 shares during the last quarter. Hedge funds and other institutional investors own 79.49% of the company’s stock.

A number of research firms have recently issued reports on DHR. Wolfe Research began coverage on shares of Danaher in a research report on Thursday, May 30th. They issued an “outperform” rating on the stock. Zacks Investment Research upgraded shares of Danaher from a “sell” rating to a “hold” rating in a research report on Monday, May 6th. Piper Jaffray Companies raised their price target on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a research report on Thursday, July 18th. Needham & Company LLC restated a “buy” rating and issued a $155.00 price target (up from $142.00) on shares of Danaher in a research report on Friday, July 19th. Finally, Argus raised their price target on shares of Danaher to $165.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $143.54.



NYSE:DHR traded down $4.16 during mid-day trading on Friday, hitting $135.40. The stock had a trading volume of 1,547,247 shares, compared to its average volume of 1,902,366. The stock has a market capitalization of $100.66 billion, a price-to-earnings ratio of 29.96, a P/E/G ratio of 2.53 and a beta of 0.94. The company has a 50 day simple moving average of $140.83 and a 200-day simple moving average of $132.29. Danaher Co. has a 52 week low of $94.59 and a 52 week high of $145.50. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.15 by $0.04. The firm had revenue of $5.16 billion for the quarter, compared to the consensus estimate of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. Danaher’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period last year, the firm posted $1.15 EPS. As a group, equities research analysts anticipate that Danaher Co. will post 4.79 earnings per share for the current year.

In related news, insider Brian W. Ellis sold 1,010 shares of Danaher stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $144.04, for a total value of $145,480.40. Following the sale, the insider now directly owns 20,889 shares in the company, valued at approximately $3,008,851.56. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Robert S. Lutz sold 14,668 shares of Danaher stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $143.28, for a total transaction of $2,101,631.04. Following the completion of the sale, the chief accounting officer now owns 21,054 shares in the company, valued at $3,016,617.12. The disclosure for this sale can be found here. Over the last quarter, insiders sold 190,152 shares of company stock worth $26,858,293. 11.40% of the stock is currently owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: What are momentum indicators and what do they show?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.